Fortress Biotech, Inc.
FBIO
$2.31
$0.093.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.07M | 17.03M | 15.01M | 13.14M | 14.12M |
| Total Other Revenue | 13.00K | 606.00K | 1.40M | -- | 1.00M |
| Total Revenue | 16.08M | 17.63M | 16.41M | 13.14M | 15.12M |
| Cost of Revenue | 5.07M | 5.96M | 13.07M | 8.73M | 14.62M |
| Gross Profit | 11.01M | 11.67M | 3.35M | 4.41M | 500.00K |
| SG&A Expenses | 14.73M | 17.42M | 38.76M | 25.66M | 26.86M |
| Depreciation & Amortization | 1.07M | 1.06M | 1.06M | 1.07M | 981.00K |
| Other Operating Expenses | -- | -- | -- | -- | -4.55M |
| Total Operating Expenses | 20.87M | 24.44M | 52.89M | 35.46M | 37.91M |
| Operating Income | -4.79M | -6.81M | -36.47M | -22.32M | -22.79M |
| Income Before Tax | -6.21M | 8.85M | -11.65M | -24.69M | -25.98M |
| Income Tax Expenses | -816.00K | 26.00K | -- | -- | 336.00K |
| Earnings from Continuing Operations | -5.40M | 8.83M | -11.65M | -24.69M | -26.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.46M | -2.98M | 27.14M | 14.11M | 19.55M |
| Net Income | -3.94M | 5.85M | 15.49M | -10.58M | -6.77M |
| EBIT | -4.79M | -6.81M | -36.47M | -22.32M | -22.79M |
| EBITDA | -3.63M | -5.65M | -35.32M | -21.13M | -21.67M |
| EPS Basic | -0.20 | 0.13 | 0.50 | -0.48 | -0.37 |
| Normalized Basic EPS | -0.08 | 0.44 | 0.11 | -0.05 | 0.15 |
| EPS Diluted | -0.20 | 0.11 | 0.45 | -0.48 | -0.37 |
| Normalized Diluted EPS | -0.08 | 0.36 | 0.10 | -0.05 | 0.15 |
| Average Basic Shares Outstanding | 30.38M | 27.24M | 26.88M | 26.45M | 26.01M |
| Average Diluted Shares Outstanding | 30.38M | 33.10M | 29.82M | 26.45M | 26.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | 0.00% |